Results 61 to 70 of about 56,585 (263)

Covid-19 vaccination and possible link to Herpes zoster

American Journal of Ophthalmology Case Reports, 2022
Purpose: To report 3 otherwise healthy patients with Herpes zoster reactivation shortly after administration of a mRNA vaccine against the novel COVID-19 virus.
D.R. Lazzaro, R. Ramachandran, E. Cohen, S.L. Galetta   +3 more
doaj  

Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.

PLoS ONE, 2021
ObjectivesComprehensive cost-effectiveness analyses of introducing varicella and/or herpes zoster vaccination in the Swedish national vaccination programme.DesignCost-effectiveness analyses based on epidemiological results from a specifically developed ...
Ellen Wolff, Katarina Widgren, Gianpaolo Scalia Tomba, Adam Roth, Tiia Lep, Sören Andersson   +5 more
doaj   +1 more source

EdgeMixup: Improving Fairness for Skin Disease Classification and Segmentation [PDF]

arXiv, 2022
Skin lesions can be an early indicator of a wide range of infectious and other diseases. The use of deep learning (DL) models to diagnose skin lesions has great potential in assisting clinicians with prescreening patients. However, these models often learn biases inherent in training data, which can lead to a performance gap in the diagnosis of people ...
arxiv  

Herpes Zoster Vaccination

The Korean Journal of Pain, 2013
Varicella (chickenpox) is a highly contagious airborne disease caused by primary infection with the varicella zoster virus (VZV). Following the resolution of chickenpox, the virus can remain dormant in the dorsal sensory and cranial ganglion for decades.
openaire   +3 more sources

Systematic evaluation of the pharmacoeconomics research on herpes zoster vaccine administration: a systematic review

Zhongguo gonggong weisheng
ObjectiveTo systematically evaluate the pharmacoeconomic research on herpes zoster (HZ) vaccine administration, providing reference for related research and prevention of HZ.
Xinping LIU, Ziyi YANG, Xinyu LI, Yulan CHANG, Lei TIAN   +4 more
doaj   +1 more source

Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study

The Lancet Public Health, 2018
Background: In 2013, a herpes zoster vaccination programme was introduced in England for adults aged 70 years with a phased catch-up programme for those aged 71–79 years.
Gayatri Amirthalingam, MFPH, Nick Andrews, PhD, Philip Keel, MSc, David Mullett, MA, Ana Correa, MSc, Simon de Lusignan, MD, Mary Ramsay, FFPH   +6 more
doaj   +1 more source

Complications and cost estimations in herpes zoster – a retrospective analysis at a Swiss tertiary dermatology clinic

Swiss Medical Weekly, 2021
INTRODUCTION: Herpes zoster is the common reactivation of latent varicella zoster virus infection and is associated with substantial morbidity and costs.
Leonard D. Bongers, Alexander Navarini, Christoph T. Berger, Simon M. Mueller   +3 more
doaj   +1 more source

Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting

Annals of Internal Medicine
BACKGROUND A 2-dose series of recombinant zoster vaccine (RZV) was 97% effective against herpes zoster (HZ) in a pivotal clinical trial. OBJECTIVE To evaluate real-world effectiveness of RZV against HZ. DESIGN Prospective cohort study. SETTING Four
Ousseny Zerbo, J. Bartlett, Bruce Fireman, N. Lewis, Kristin Goddard, K. Dooling, J. Duffy, J. Glanz, Allison L Naleway, James G Donahue, Nicola P. Klein   +10 more
semanticscholar   +1 more source

AIRIVA: A Deep Generative Model of Adaptive Immune Repertoires [PDF]

arXiv, 2023
Recent advances in immunomics have shown that T-cell receptor (TCR) signatures can accurately predict active or recent infection by leveraging the high specificity of TCR binding to disease antigens. However, the extreme diversity of the adaptive immune repertoire presents challenges in reliably identifying disease-specific TCRs.
arxiv  

Zoster vaccination is associated with a reduction of zoster in elderly patients with chronic kidney disease. [PDF]

, 2016
BACKGROUND: Growing epidemiological evidence demonstrates increased zoster risks in people with chronic kidney disease (CKD). Study objectives were to determine zoster vaccine effectiveness in individuals with CKD in pragmatic use.
Langan, Sinéad M, Margolis, David J, Nitsch, Dorothea, Smeeth, Liam, Thomas, Sara L   +4 more
core   +1 more source